Premium
Thesis Gold & Silver Inc (QX) (THSGF)
USOTC
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-25 | Dr. Thomas MumfordIndependent Director | 1,58k | 3,16k | Achat | 2,00 | 290,35k | 0,55% |
| 2026-06-08 | Dr. Thomas MumfordIndependent Director | 5,00k | 11,00k | Achat | 2,20 | 288,78k | 1,76% |
| 2026-03-27 | Mr. Nicholas StajduharVP of Corporate Development | -200,00k | 468,56k | Vente | 2,34 | 193,60k | -50,81% |
| 2026-03-27 | Mr. Nicholas StajduharVP of Corporate Development | 298,40k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,93 - 1,95 | 433,40k | 221,04% |
| 2026-03-11 | Mr. Nicholas StajduharVP of Corporate Development | 393,60k | 198,10k | Derivative Exercise and Retained Stock | 0,36 - 0,93 | 193,60k | -196,80% |
| 2026-05-06 | Dr. Ewan Russell WebsterPresident, CEO & Director | 98,40k | 91,74k | Derivative Exercise and Retained Stock | 0,93 | 803,80k | 13,95% |
| 2026-03-11 | Dr. Ewan Russell WebsterPresident, CEO & Director | 295,20k | 106,36k | Derivative Exercise and Retained Stock | 0,36 | 803,80k | 58,04% |
| 2026-03-11 | Dr. Ewan Russell WebsterPresident, CEO & Director | -144,00k | 354,68k | Vente | 2,46 - 2,47 | 803,80k | -15,19% |
| 2026-03-27 | Mr. David GarrattCFO & Corporate Secretary | 120,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,95 | 370,00k | 48,00% |
| 2026-03-27 | Dr. Ewan Russell WebsterPresident, CEO & Director | 200,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,95 | 2,54M | 8,55% |
| 2025-07-31 | Mr. David GarrattCFO & Corporate Secretary | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 250,00k | - |
| 2026-03-27 | Mr. Nicholas StajduharVP of Corporate Development | 135,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 1,95 | 135,00k | - |
| 2024-03-13 | Dr. Ewan Russell WebsterPresident, CEO & Director | 1 000,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,35 | 2,34M | 74,64% |
| 2025-07-31 | Mr. David GarrattCFO & Corporate Secretary | 250,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 0,69 | 250,00k | - |
| 2025-08-06 | Mr. Russell David BallIndependent Director | 5,00k | 3,75k | Achat | 0,75 | 5,00k | - |
| 2025-07-31 | Ms. Lisa M. PetersonIndependent Director | 2,00k | 1,37k | Achat | 0,69 | 14,00k | 16,67% |
| 2025-07-31 | Dr. Thomas MumfordIndependent Director | 6,54k | 4,30k | Achat | 0,66 | 283,78k | 2,36% |
| 2025-07-17 | Dr. Thomas MumfordIndependent Director | 6,50k | 4,63k | Achat | 0,71 | 277,24k | 2,40% |
| 2025-07-16 | Dr. Ewan Russell WebsterPresident, CEO & Director | 5,00k | 0,00 | Achat | - | 554,20k | 0,91% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
